203 related articles for article (PubMed ID: 2182146)
1. Assessment of hypercoagulable states by measurement of activation fragments and peptides.
Boisclair MD; Ireland H; Lane DA
Blood Rev; 1990 Mar; 4(1):25-40. PubMed ID: 2182146
[TBL] [Abstract][Full Text] [Related]
2. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
3. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states.
Wilde JT; Kitchen S; Kinsey S; Greaves M; Preston FE
Br J Haematol; 1989 Jan; 71(1):65-70. PubMed ID: 2917130
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
5. D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.
Moresco RN; Vargas LC; Voegeli CF; Santos RC
J Clin Lab Anal; 2003; 17(3):77-9. PubMed ID: 12696076
[TBL] [Abstract][Full Text] [Related]
6. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
7. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
8. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
Lane DA; Preston FE; VanRoss ME; Kakkar VV
Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
[TBL] [Abstract][Full Text] [Related]
9. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
10. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
11. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
12. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Dempfle CE
Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
[TBL] [Abstract][Full Text] [Related]
13. Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock.
Yanagida Y; Gando S; Sawamura A; Hayakawa M; Uegaki S; Kubota N; Homma T; Ono Y; Honma Y; Wada T; Jesmin S
Surgery; 2013 Jul; 154(1):48-57. PubMed ID: 23684364
[TBL] [Abstract][Full Text] [Related]
14. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
15. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; OcaƱa J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
16. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC).
Bick RL; Baker WF
Thromb Res; 1992 Mar; 65(6):785-90. PubMed ID: 1636167
[TBL] [Abstract][Full Text] [Related]
18. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
Koike K; Fujimaki M
Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
[TBL] [Abstract][Full Text] [Related]
19. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
Ohsato K; Okamoto K
Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
[TBL] [Abstract][Full Text] [Related]
20. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
Song KS; Kim YA; Kim HK; Park Q
Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]